PL2807172T3 - Pochodne pirymidooksazocyny jako inhibitory mTOR - Google Patents

Pochodne pirymidooksazocyny jako inhibitory mTOR

Info

Publication number
PL2807172T3
PL2807172T3 PL13712331T PL13712331T PL2807172T3 PL 2807172 T3 PL2807172 T3 PL 2807172T3 PL 13712331 T PL13712331 T PL 13712331T PL 13712331 T PL13712331 T PL 13712331T PL 2807172 T3 PL2807172 T3 PL 2807172T3
Authority
PL
Poland
Prior art keywords
pyrimidooxazocine
mtor
inhibitors
derivatives
pyrimidooxazocine derivatives
Prior art date
Application number
PL13712331T
Other languages
English (en)
Inventor
Alain Braun
Olivier Crespin
Yann Foricher
Gilbert Marciniak
Nicolas Muzet
Eric Nicolai
Cécile Pascal
Bertrand Vivet
Fabrice Viviani
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of PL2807172T3 publication Critical patent/PL2807172T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL13712331T 2012-01-26 2013-01-25 Pochodne pirymidooksazocyny jako inhibitory mTOR PL2807172T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1250768A FR2986232B1 (fr) 2012-01-26 2012-01-26 Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique
EP13712331.1A EP2807172B1 (en) 2012-01-26 2013-01-25 Pyrimidooxazocine derivatives as mtor-inhibitors

Publications (1)

Publication Number Publication Date
PL2807172T3 true PL2807172T3 (pl) 2017-05-31

Family

ID=47997597

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13712331T PL2807172T3 (pl) 2012-01-26 2013-01-25 Pochodne pirymidooksazocyny jako inhibitory mTOR

Country Status (26)

Country Link
US (1) US9120812B2 (pl)
EP (1) EP2807172B1 (pl)
JP (1) JP6068508B2 (pl)
KR (1) KR20140125389A (pl)
CN (1) CN104203958B (pl)
AR (1) AR089782A1 (pl)
AU (1) AU2013213261B2 (pl)
BR (1) BR112014018226A8 (pl)
CA (1) CA2862747A1 (pl)
CY (1) CY1118852T1 (pl)
DK (1) DK2807172T3 (pl)
ES (1) ES2617880T3 (pl)
FR (1) FR2986232B1 (pl)
HR (1) HRP20170288T1 (pl)
HU (1) HUE031917T2 (pl)
IL (1) IL233774A (pl)
LT (1) LT2807172T (pl)
MX (1) MX348841B (pl)
PL (1) PL2807172T3 (pl)
PT (1) PT2807172T (pl)
RU (1) RU2627269C2 (pl)
SG (1) SG11201404325VA (pl)
SI (1) SI2807172T1 (pl)
TW (1) TWI572608B (pl)
UY (1) UY34594A (pl)
WO (1) WO2013111106A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6139789B2 (ja) * 2013-10-16 2017-05-31 シャンハイ インリ ファーマシューティカル カンパニー リミティド 縮合複素環化合物、その調製方法、医薬組成物及びその使用
CN107001317B (zh) * 2014-09-29 2019-05-24 山东轩竹医药科技有限公司 高选择性取代嘧啶类pi3k抑制剂
US10307707B2 (en) * 2017-05-17 2019-06-04 Thomas P. Daly 1-amino-2-methyl-2-propanol derivatives
EP3849535A4 (en) 2018-09-10 2022-06-29 Mirati Therapeutics, Inc. Combination therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100887471B1 (ko) * 2002-01-18 2009-03-10 교린 세이야꾸 가부시키 가이샤 축합 바이사이클릭 피리미딘 유도체
CA2514473C (en) * 2002-11-22 2008-05-27 Japan Tobacco Inc. Fused bicyclic nitrogen-containing heterocycles
EP2382207B1 (en) * 2008-11-11 2015-04-29 Xcovery Holding Company LLC Pi3k/mtor kinase inhibitors
MX2011012584A (es) * 2009-05-26 2012-02-21 Exelixis Inc Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
CA2799764A1 (en) * 2010-05-19 2011-11-24 Xcovery Holding Company, Llc. Mtor selective kinase inhibitors

Also Published As

Publication number Publication date
PT2807172T (pt) 2017-03-06
ES2617880T3 (es) 2017-06-20
SG11201404325VA (en) 2014-08-28
MX2014009084A (es) 2015-02-05
US20140378433A1 (en) 2014-12-25
HRP20170288T1 (hr) 2017-04-21
AU2013213261B2 (en) 2017-07-20
WO2013111106A1 (en) 2013-08-01
RU2627269C2 (ru) 2017-08-04
DK2807172T3 (en) 2017-03-06
JP6068508B2 (ja) 2017-01-25
HUE031917T2 (en) 2017-08-28
SI2807172T1 (sl) 2017-03-31
US9120812B2 (en) 2015-09-01
CA2862747A1 (en) 2013-08-01
BR112014018226A2 (pl) 2017-06-20
MX348841B (es) 2017-06-30
CN104203958B (zh) 2017-05-31
JP2015504914A (ja) 2015-02-16
FR2986232A1 (fr) 2013-08-02
AR089782A1 (es) 2014-09-17
EP2807172A1 (en) 2014-12-03
TWI572608B (zh) 2017-03-01
KR20140125389A (ko) 2014-10-28
FR2986232B1 (fr) 2014-02-14
TW201333016A (zh) 2013-08-16
CN104203958A (zh) 2014-12-10
LT2807172T (lt) 2017-03-27
CY1118852T1 (el) 2018-01-10
RU2014134640A (ru) 2016-03-27
UY34594A (es) 2013-09-02
IL233774A (en) 2016-06-30
AU2013213261A1 (en) 2014-08-21
BR112014018226A8 (pt) 2017-07-11
EP2807172B1 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
HUS2200040I1 (hu) Benzimidazol-prolin származékok
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1205508A1 (en) New bicyclicpyridine derivatives
HK1207363A1 (en) Novel indanesulfamide derivative
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
LT2838883T (lt) Nauji feniltetrahidroizochinolino dariniai
HK1200824A1 (en) Substituted phenylazole derivative
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
PL2873660T3 (pl) Pochodna indolokarboksyamidu
EP2842958A4 (en) NAPHTHOBISTHIADIAZOLDERIVAT
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-